Are Most Medical Cannabis Products Unlicensed in the UK?

Medical cannabis has been a subject of growing interest and controversy in the UK over recent years. Patients and healthcare professionals alike navigate a complex legal and regulatory landscape, often encountering the phrase “unlicensed category” when discussing these products. But what does it mean for a medical cannabis product to be unlicensed, and why is it significant that most products fall into this category?

In this article, we explore the status of medical cannabis in the UK, referring closely to the GOV.UK guidance for prescribers. Alongside, we delve into some less-discussed yet vital band of psychological factors involved when managing medical cannabis therapies—particularly relating to performance science principles such as the inverted-U arousal curve, pre-session cognitive routines, and the difference between process-focused and outcome-focused attention.

What Does “Unlicensed” Mean in the Context of Medical Cannabis?

In the UK, medicines are typically licensed after receiving a MHRA (Medicines and Healthcare products Regulatory Agency) marketing authorisation. This authorisation essentially means the product has undergone rigorous safety, quality, and efficacy testing. However, most medical cannabis products do not have this MHRA marketing authorisation. Instead, they fall under an unlicensed category.

Products in this unlicensed category often include various cannabis oils, tinctures, and flower products that have been imported or prepared specifically for individual patients. Because they lack full licensing, these products:

Have not passed the formal MHRA approval process Are prescribed on a "named patient" basis (i.e., specifically for an individual patient) Are usually prescribed by a specialist prescriber — a doctor authorised and experienced in this field rather than general practitioners Require careful clinical monitoring due to variability in product content and effects

The “Named Patient” and “Specialist Prescriber” System

According to GOV.UK’s guidance, unlicensed cannabis-based products for medicinal use (CBPMs) should be prescribed under the following conditions:

The product is prescribed on a named patient basis. The prescriber is a specialist familiar with the patient’s condition and the unlicensed product's specifics. The patient should have tried conventional treatments first, or there must be a clear rationale to bypass them. Careful monitoring and documentation of outcomes are essential.

As a result, while medical cannabis is legally prescribable, it is often seen as a last resort rather than a frontline therapy — partly because the evidence base is still developing, but also because of the regulatory hurdles around licensing.

Why This Matters: Perhaps More Than Just Legal Labels

Many patients and health professionals get stuck on the label “unlicensed” and worry it implies lesser quality or safety. However, an unlicensed product simply denotes a different stage of regulatory approval and doesn’t automatically mean unsafe. That said, the lack of licensing does imply the need for very careful patient management and realistic expectations.

This is where an understanding of cognitive and physiological self-management techniques around medical cannabis use becomes important—especially when considering the drug’s impact on neurological and psychological functioning. If you’ve ever felt fuzzy-headed or jittery after a cannabis dose, or unsteady in gauging the right amount, you’re facing challenges that go beyond the pharmacology. Let’s pull in some frameworks from psychophysiology and performance psychology that can help make sense of it all.

The Inverted-U Arousal Curve & Performance Band

A useful concept to understand the mind’s response to stressors and performance enhancers is the inverted-U arousal curve. This model, coming from sports psychology and human factors research, suggests that performance improves with arousal up to a point; beyond that, additional arousal causes performance to deteriorate.

Arousal Level Performance Effect Example Symptoms Low (Under-aroused) Suboptimal performance, lethargy Fatigue, inattentiveness Optimal (Mid-range) Peak performance, focus, control Alertness, calm concentration High (Over-aroused) Declining performance, anxiety, jitteriness Nervousness, racing thoughts, loss of control

Medical cannabis can shift a patient’s arousal level by affecting cognition, mood, and physical sensations. For some it can help move towards optimal arousal, especially when pain or anxiety blocks concentration. For others, especially at higher doses or with certain strains, how to lower heart rate grid it can push arousal levels too high, impairing working memory, decision making, and emotional control.

Understanding this curve can help both prescribers and patients better judge dose and product choice, ultimately aiming to keep effects within that performance band where benefits are maximised without triggering excessive side effects.

Pre-Session Routine: Managing Working Memory and Expectation

If you’ve read our prior columns on race preparation, you’ll know we often ask: What would you do in the 2 minutes before it starts? This question hits on routines that regulate attention and working memory—the brain’s short-term scratchpad for juggling thoughts and plans.

Medical cannabis patients can benefit hugely from establishing simple pre-consumption routines. Why? Because working memory is vulnerable to high arousal and cognitive load, both of which cannabis can amplify if not carefully managed. A consistent pre-dose routine helps:

Clear distracting thoughts and worries Set clear, realistic goals for the session or time after consumption Balance mental focus toward process rather than outcome (more on this next)

A routine could be as simple as:

5 deep breaths (extended exhales, explained below) Brief review of key tasks or symptoms to monitor Setting an intention: “I will focus on noticing effects without judgment”

This kind of cognitive scaffolding helps contain intrusive or racing thoughts, which commonly undermine successful therapeutic use.

Extended-Exhale Breathing for Quick Physiological Shift

One tried-and-true physiological hack is the extended-exhale breathing technique, known to rapidly shift the body from sympathetic (fight-or-flight) dominance toward parasympathetic calm.

Here’s why this matters: dosing on medical cannabis can sometimes lead to unwanted racing heart, jitteriness, or anxious energy. Simple controlled breathing can quickly reset your autonomic state, reducing over-arousal and helping tip you back onto that sweet spot of the inverted-U curve.

How to practice extended-exhale breathing:

Inhale gently through your nose for about 4 seconds. Pause for 1-2 seconds. Exhale slowly through your mouth for about 6-8 seconds—longer than the inhale. Pause again briefly at end of exhale. Repeat for several cycles until you feel more grounded.

This technique works both physiologically by stimulating the vagus nerve and psychologically by redirecting your focus toward your breath rather than racing thoughts.

External Process-Focused Attention vs Outcome Focus

Mindset makes a measurable difference in managing any treatment’s effects, cannabis included. Many patients fall into an outcome-focused mindset—constantly monitoring whether the medicine is “working” or not. This can increase performance pressure on the brain’s circuits, ironically making symptoms worse or feedback more confusing.

A better alternative is cultivating an external process-focused attention. This means:

Paying attention to specific sensations, routines, or tasks outside of yourself Engaging in simple external activities such as walking, stretching, or listening carefully Using external reference points to ground your awareness rather than your internal anticipation

This approach reduces self-monitoring loops that can overload working memory and arousal systems, making effective cannabis management easier and more consistent.

Summary and Takeaway for Patients and Clinicians

To answer the question raised in the title: Yes, the vast majority of medical cannabis products currently prescribed in the UK fall into an unlicensed category, meaning they lack MHRA marketing authorisation and are issued on a named patient basis by specialist prescribers following stringent guidelines.

However, managing this innovative and sometimes complex therapy benefits enormously from embracing principles beyond the pharmacological. Understanding your own mind’s arousal levels, setting effective pre-consumption routines, mastering simple breathing techniques, and focusing on external process cues rather than outcome obsession—these can all dramatically improve the odds of a positive experience.

For patients navigating this terrain, always ensure prescriptions come through qualified channels and that you work closely with your specialist prescriber. For healthcare professionals, be patient, pragmatic, and educate on self-management techniques https://varimail.com/articles/can-a-gp-prescribe-medical-cannabis-in-the-uk/ that bolster not only medication effects but also patient confidence and safety.

Share Your Experiences & Join the Conversation

If you found this article helpful, please consider sharing it on your favourite social platform:

Facebook Twitter/X Reddit LinkedIn Pinterest

Your feedback and questions are welcome—how have you or your patients managed the psychological challenges of medical cannabis? Let’s keep this discussion grounded in clear practical steps, honest experience, and scientific rigour.